St. Petersburg, FL

Theia Clinical Research

Bacterial Infections and Mycoses

Actinomycetales Infections

Bacterial Infections

Nontuberculous Mycobacterium Infections

Mycobacterium avium-intracellulare Infection

Respiratory Tract Diseases

Bronchiectasis

Respiratory Tract Infections

Infections

Mycobacterium Infections

Clofazimine

MNKD-101

MannKind

condition

Gram-Positive Bacterial Infections

Lung Diseases

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Theia Clinical Research | St. Petersburg, FL

Site insights

Work at this site?

Active trials

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Trial sponsors